Rotten Tomato Stocks
No Result
View All Result
  • News
    Park Outside: Hyundai, Kia Recall Vehicles Due to Fire Risk

    Park Outside: Hyundai, Kia Recall Vehicles Due to Fire Risk

    Stocks Fall, Bond Yields Tumble After Fed’s Latest Rate Hike

    Stocks Fall, Bond Yields Tumble After Fed’s Latest Rate Hike

    First Majestic Shares Drop After Mining at Nevada Operation Suspended

    First Majestic Shares Drop After Mining at Nevada Operation Suspended

    Wheat Futures Fall After Export Deal Reached

    Wheat Futures Fall After Export Deal Reached

  • NYSE
    Kellogg (NYSE:K) Takes On Some Risk With Its Use Of Debt

    Kellogg (NYSE:K) Takes On Some Risk With Its Use Of Debt

    UnitedHealth Group Inc. stock falls Thursday, underperforms market

    UnitedHealth Group Inc. stock falls Thursday, underperforms market

    Chewy stock dips as earnings show shrinking customer count, forecast of no profit growth

    Chewy stock dips as earnings show shrinking customer count, forecast of no profit growth

    Nike stock turns lower, as enduring costs, markdowns weigh on margins

    Nike stock turns lower, as enduring costs, markdowns weigh on margins

  • NASDAQ
    Cidara Therapeutics Down 3% After Hours Following FDA Approval

    Cidara Therapeutics Down 3% After Hours Following FDA Approval

    Xerox Holdings Corp. stock falls Thursday, underperforms market

    Xerox Holdings Corp. stock falls Thursday, underperforms market

    Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week Low After Analyst Downgrade

    Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week Low After Analyst Downgrade

    Petco Shares Sink 13% After Issuing FY23 Guidance

    Petco Shares Sink 13% After Issuing FY23 Guidance

  • OTC
    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    Corus Entertainment 4Q Profit Falls

    Corus Entertainment 4Q Profit Falls

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

  • TSX
    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    Bitcoin Is Falling: Should You Buy the Dip?

    Bitcoin Is Falling: Should You Buy the Dip?

    CN Rail Stock Is So Undervalued That it’s Absurd

    CN Rail Stock Is So Undervalued That it’s Absurd

  • News
    Park Outside: Hyundai, Kia Recall Vehicles Due to Fire Risk

    Park Outside: Hyundai, Kia Recall Vehicles Due to Fire Risk

    Stocks Fall, Bond Yields Tumble After Fed’s Latest Rate Hike

    Stocks Fall, Bond Yields Tumble After Fed’s Latest Rate Hike

    First Majestic Shares Drop After Mining at Nevada Operation Suspended

    First Majestic Shares Drop After Mining at Nevada Operation Suspended

    Wheat Futures Fall After Export Deal Reached

    Wheat Futures Fall After Export Deal Reached

  • NYSE
    Kellogg (NYSE:K) Takes On Some Risk With Its Use Of Debt

    Kellogg (NYSE:K) Takes On Some Risk With Its Use Of Debt

    UnitedHealth Group Inc. stock falls Thursday, underperforms market

    UnitedHealth Group Inc. stock falls Thursday, underperforms market

    Chewy stock dips as earnings show shrinking customer count, forecast of no profit growth

    Chewy stock dips as earnings show shrinking customer count, forecast of no profit growth

    Nike stock turns lower, as enduring costs, markdowns weigh on margins

    Nike stock turns lower, as enduring costs, markdowns weigh on margins

  • NASDAQ
    Cidara Therapeutics Down 3% After Hours Following FDA Approval

    Cidara Therapeutics Down 3% After Hours Following FDA Approval

    Xerox Holdings Corp. stock falls Thursday, underperforms market

    Xerox Holdings Corp. stock falls Thursday, underperforms market

    Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week Low After Analyst Downgrade

    Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week Low After Analyst Downgrade

    Petco Shares Sink 13% After Issuing FY23 Guidance

    Petco Shares Sink 13% After Issuing FY23 Guidance

  • OTC
    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    China Eastern Airlines 3Q Loss Widens on Low Travel Demand

    Corus Entertainment 4Q Profit Falls

    Corus Entertainment 4Q Profit Falls

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Nintendo Co. Ltd. ADR falls Monday, still outperforms market

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

    Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

  • TSX
    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    S&P/TSX composite falls on drop in materials sector, loonie tops 81 cents US

    Bitcoin Is Falling: Should You Buy the Dip?

    Bitcoin Is Falling: Should You Buy the Dip?

    CN Rail Stock Is So Undervalued That it’s Absurd

    CN Rail Stock Is So Undervalued That it’s Absurd

No Result
View All Result
Rotten Tomato Stocks
No Result
View All Result

Concert Pharmaceuticals’ (NASDAQ:CNCE) Shareholders Are Down 80% On Their Shares

Editorial Staff by Editorial Staff
May 25, 2021
0
Concert Pharmaceuticals’ (NASDAQ:CNCE) Shareholders Are Down 80% On Their Shares

It’s not possible to invest over long periods without making some bad investments. But really bad investments should be rare. So spare a thought for the long term shareholders of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE); the share price is down a whopping 80% in the last three years. That might cause some serious doubts about the merits of the initial decision to buy the stock, to put it mildly. The more recent news is of little comfort, with the share price down 61% in a year. The falls have accelerated recently, with the share price down 42% in the last three months. This could be related to the recent financial results – you can catch up on the most recent data by reading our company report.

While a drop like that is definitely a body blow, money isn’t as important as health and happiness.

Because Concert Pharmaceuticals made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Shareholders of unprofitable companies usually expect strong revenue growth. That’s because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

Over the last three years, Concert Pharmaceuticals’ revenue dropped 20% per year. That’s definitely a weaker result than most pre-profit companies report. The swift share price decline at an annual compound rate of 22%, reflects this weak fundamental performance. We prefer leave it to clowns to try to catch falling knives, like this stock. There is a good reason that investors often describe buying a sharply falling stock price as ‘trying to catch a falling knife’. Think about it.

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

earnings-and-revenue-growth

A Different Perspective

Investors in Concert Pharmaceuticals had a tough year, with a total loss of 61%, against a market gain of about 49%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, last year’s performance may indicate unresolved challenges, given that it was worse than the annualised loss of 11% over the last half decade. We realise that Baron Rothschild has said investors should “buy when there is blood on the streets”, but we caution that investors should first be sure they are buying a high quality business. It’s always interesting to track share price performance over the longer term. But to understand Concert Pharmaceuticals better, we need to consider many other factors. 

Related Posts

Cidara Therapeutics Down 3% After Hours Following FDA Approval
NASDAQ

Cidara Therapeutics Down 3% After Hours Following FDA Approval

March 24, 2023
Xerox Holdings Corp. stock falls Thursday, underperforms market
NASDAQ

Xerox Holdings Corp. stock falls Thursday, underperforms market

March 24, 2023
Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week Low After Analyst Downgrade
NASDAQ

Mineralys Therapeutics (NASDAQ:MLYS) Reaches New 52-Week Low After Analyst Downgrade

March 24, 2023
Petco Shares Sink 13% After Issuing FY23 Guidance
NASDAQ

Petco Shares Sink 13% After Issuing FY23 Guidance

March 22, 2023
Load More
Next Post
Is Landec (NASDAQ:LNDC) Using Too Much Debt?

Is Landec (NASDAQ:LNDC) Using Too Much Debt?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

POPULAR NEWS

CNH Industrial (NYSE:CNHI) Use Of Debt Could Be Considered Risky

CNH Industrial (NYSE:CNHI) Use Of Debt Could Be Considered Risky

April 14, 2021
CN Rail Stock Is So Undervalued That it’s Absurd

CN Rail Stock Is So Undervalued That it’s Absurd

May 2, 2021
US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

US Seeks to Fine Air Canada $25.5 Million Over Slow Refunds

June 17, 2021
Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

Ocado Group PLC Revenue of Ocado Retail in Q3 Fell 10.6%

September 14, 2021
10 Warning Signs That Should Tell You “This Stock is in Trouble”

10 Warning Signs That Should Tell You “This Stock is in Trouble”

November 11, 2019

EDITOR'S PICK

Sliding Vaccine Sales, New Costs, Squeeze Moderna 4Q Profit

Sliding Vaccine Sales, New Costs, Squeeze Moderna 4Q Profit

February 23, 2023
How Does Genpact’s (NYSE:G) P/E Compare To Its Industry, After The Share Price Drop?

How Does Genpact’s (NYSE:G) P/E Compare To Its Industry, After The Share Price Drop?

April 1, 2021
Is TriMas (NASDAQ:TRS) Using Too Much Debt?

Is TriMas (NASDAQ:TRS) Using Too Much Debt?

August 12, 2021
Caesars stock drops after surprising loss, but recovers after moving up plans to sell a Vegas casino

Caesars stock drops after surprising loss, but recovers after moving up plans to sell a Vegas casino

November 3, 2021

Stay Updated

Get breaking news delivered straight into your inbox

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Rotten Tomato stocks is a wholly-owned subsidiary of Grainne Capital Limited.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Rotten Tomato Stocks cover the companies and markets that are declining, failing or headed for disaster. We help investors spot the down tends and recognize when something smells rotten.

RECENT POSTS

Park Outside: Hyundai, Kia Recall Vehicles Due to Fire Risk

Kellogg (NYSE:K) Takes On Some Risk With Its Use Of Debt

UnitedHealth Group Inc. stock falls Thursday, underperforms market

POPULAR POSTS

Chewy stock dips as earnings show shrinking customer count, forecast of no profit growth

Cidara Therapeutics Down 3% After Hours Following FDA Approval

Xerox Holdings Corp. stock falls Thursday, underperforms market

© Copyright 2023 RottenTomatoStocks. All Rights Reserved 

Disclaimer | Privacy Policy

No Result
View All Result
  • HOME
  • NEWS
  • NYSE
  • NASDAQ
  • OTC
  • TSX

© 2021 RottenTomatoStocks.com

error: Content is protected !!
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.